Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLCORONA-COVID-19 colchicine outpatient trial
2020-001689-12Phase 3Completed
- Sponsor
- Montréal Heart Institute
- Start
- Apr 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of colchicine in coronavirus disease 2019 (COVID-19), sponsored by Montréal Heart Institute. Primary endpoint: Composite of death or hospitalization due to COVID-19. Started Apr 2020; status: completed.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001689-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001689-12.